<DOC>
	<DOCNO>NCT01072994</DOCNO>
	<brief_summary>Despite aggressive treatment , patient heart failure poor prognosis . Docosahexaenoic acid ( DHA ) , omega-3 polyunsaturated fatty acid find fish oil , may prevent progression heart failure mechanism address current drug . The omega-3 polyunsaturated fatty acid Docosahexaenoic Acid ( DHA ) Eicosapentaenoic acid ( EPA ) favorably impact mitochondrial dysfunction chronic inflammation heart failure ( HF ) . Treatment DHA-t-EPA alters cardiac phospholipid composition decrease arachidonic acid ( pro-inflammatory fatty acid ) increase DHA mitochondrial phospholipid cardiolipin , associate improved Left Ventricular ( LV ) function . Fish oil supplement contain mix DHA EPA , however postulate DHA superior EPA improve mitochondrial function suppress inflammation , thus DHA use treat HF . Cardiac phospholipid fatty acid composition ( i.e . DHA , EPA , arachidonic acid ) cardiolipin ( CL ) content measure biopsy stable heart transplantation patient obtain part standard clinical care heart transplant patient treatment DHA alone DHA+EPA . We compare cardiac phospholipid composition biopsy obtain study entry 6 month follow-up ( allowable range +/- two month , depend patient ' clinical condition ) .</brief_summary>
	<brief_title>Fish Oil In Heart Transplantation</brief_title>
	<detailed_description>50 adult heart transplant recipient ( 18-75 year age ) enter maintenance phase ( &gt; 6 month heart transplantation ) , remain clinically quiescent ( See Inclusion criterion ) undergo regularly schedule myocardial biopsy ( part standard clinical care ) allograft rejection recruit . Half subject receive DHA half DHA+EPA administer orally administer two capsule morning two evening . Each patient serve control , comparison make pre post treatment within patient . Prior assignment treatment , septal biopsy ( 10 20 mg ) obtain routine biopsy procedure immediately frozen liquid nitrogen store -80 analysis . Therapy continue least 6 month completion primary end point pair cardiac biopsy acquisition . Cardiac biopsy obtain regularly schedule myocardial biopsy clinical evaluation allograft rejection also analyze phospholipid fatty acid composition . The study completion date list record obtain `` Completed Date '' enter Query View Report System ( QVR ) .</detailed_description>
	<criteria>1 . Age 1875 year age time cardiac transplantation ; 2 . Absence cardiac allograft rejection index cardiac biopsy 3 . No treatment cardiac allograft rejection within 30 day enrollment 4 . Absence restrictive physiology cardiac allograft dysfunction hemodynamic assessment 5 . Stable immunosuppression background medication past 30 day plan modulation therapy 6 month 6 . All woman childbearing potential must negative urine pregnancy test prior treatment agree use adequate contraception ( defined oral injectable contraceptive , intrauterine device , surgical sterilization combination condom spermicide ) limit sexual activity vasectomize partner 3 month administration therapy ; 7 . Ability sign Informed Consent Form Release Medical Information Form 1 . Regular use u ) 3 PUFA supplement ( fish oil flax seed oil ) . 2 . Alcoholism drug abuse ; 3 . Poorly control diabetes ( define Hb A1C &gt; 8 ) ; 4 . Fasting triglyceride &gt; 250 mg/dl . 5 . Pregnancy Lactation 6 . Persons know sensitivity allergy fish ;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Myocardium</keyword>
	<keyword>Phospholipid</keyword>
	<keyword>Fish oil</keyword>
	<keyword>Cardiolipin</keyword>
	<keyword>Transplantation</keyword>
</DOC>